Trouble reading this e-mail? View it in your browser.

EFPIA
Newsletter
28 February 2014
Header
Header image
Highlight of the week

Events Calendar

Rare Disease Day
On 28/02/2014

Rare Disease Day is an annual, awareness-raising event co-ordinated by EURORDIS at the international level and by National Alliances and Patient Organisations at the national [...] Read more

News

News

Business Community Welcomes Today’s Vote by the European Parliament on Counterfeit Goods in Transit and Urges Council to Follow Suit
25 February 2014

Brussels, 25 February, 2014 The undersigned organisations representing thousands of companies across all industry lines and sectors welcome today’s vote by the European Parliament of robust [...] Read more

From our blog

From our blog

How New Thinking on Industrial Policy Can Help Make a #HealthyEU
25 February 2014 by Richard Torbett

Economic policymakers often like to avoid thinking about ‘Industrial Policy’. Negative connotations stem from a history of misguided policy decisions, especially in the 1970s, where [...] Read more

Events calendar

Events Calendar

The Pharma Summit 2014
On 13/03/2014 (London)

In the last decade, life science-based innovations have been incremental rather than radical. Onerous regulations that differ from country to country, high product development costs [...] Read more

What we are reading

What we are reading

How can we speed diagnosis of rare diseases?
28 February 2014

Getting the right diagnosis is one of the greatest challenges facing people with rare diseases and their families. According to the Shire Rare Disease Impact Report, it takes on average 7.6 years in the US and on average 5.6 years in the UK for patients with a rare disease to receive a proper diagnosis; along the way they often receive two to three misdiagnoses.

Read more

What we are reading

An essential step toward printing living tissues
28 February 2014

A new bioprinting method developed at the Wyss Institute for Biologically Inspired Engineering at Harvard University and the Harvard School of Engineering and Applied Sciences (SEAS) creates intricately patterned 3D tissue constructs with multiple types of cells and tiny blood vessels. The work represents a major step toward a longstanding goal of tissue engineers: creating human tissue constructs realistic enough to test drug safety and effectiveness.

(photo credit: NatGeoTv)

Read more

About EFPIA updates
Unsubscribe to be removed from this mailing list | Update your subscription

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 34 national associations and 40 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.
Leopold Plaza Building
Rue du Trône 108
B-1050 Brussels (Belgium)
Tel: +32 (0)2 626 25 55
E-mail: communications@efpia.eu
Follow EFPIA
Twitter LinkedIn Youtube Google + Pinterest E-mail